yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q58729793-161230F0-A448-447C-ADB9-737A1D63E7AE
Q58729793-161230F0-A448-447C-ADB9-737A1D63E7AE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58729793-161230F0-A448-447C-ADB9-737A1D63E7AE
Patient-reported outcome measures for use in clinical trials of SLE: a review
P2860
Q58729793-161230F0-A448-447C-ADB9-737A1D63E7AE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58729793-161230F0-A448-447C-ADB9-737A1D63E7AE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bc0d72ab394a513ffa6c45bc69ae90331d0907fc
P2860
High dose cyclophosphamide performs better than monthly dose cyclophosphamide in quality of life measures.